X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1088) 1088
Publication (130) 130
Book Review (31) 31
Newsletter (13) 13
Book Chapter (10) 10
Book / eBook (1) 1
Conference Proceeding (1) 1
Data Set (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (965) 965
index medicus (623) 623
female (561) 561
male (536) 536
progressive multifocal leukoencephalopathy (510) 510
adult (388) 388
middle aged (353) 353
clinical neurology (299) 299
aged (259) 259
risk factors (235) 235
magnetic resonance imaging (223) 223
neurosciences (188) 188
leukoencephalopathy (176) 176
leukoencephalopathy, progressive multifocal - epidemiology (165) 165
jc virus (157) 157
prevalence (142) 142
adolescent (137) 137
retrospective studies (134) 134
virology (134) 134
natalizumab (126) 126
viruses (122) 122
research (121) 121
epidemiology (120) 120
child (119) 119
multiple sclerosis (119) 119
brain - pathology (118) 118
neurology (117) 117
disease (115) 115
immunology (114) 114
infectious diseases (112) 112
leukoencephalopathies - epidemiology (110) 110
health aspects (109) 109
young adult (109) 109
incidence (107) 107
jc virus - genetics (98) 98
aged, 80 and over (97) 97
diagnosis (96) 96
jc virus - isolation & purification (95) 95
virus diseases (95) 95
infection (94) 94
brain (93) 93
hiv (93) 93
aids (88) 88
animals (86) 86
leukoencephalopathy, progressive multifocal - diagnosis (85) 85
child, preschool (84) 84
risk (83) 83
care and treatment (81) 81
cohort studies (80) 80
prognosis (80) 80
cerebrospinal-fluid (79) 79
dementia (78) 78
article (76) 76
central-nervous-system (74) 74
stroke (74) 74
active antiretroviral therapy (73) 73
leukoencephalopathy, progressive multifocal - virology (73) 73
leukoencephalopathies - pathology (72) 72
leukoencephalopathy, progressive multifocal (70) 70
polyomavirus infections - epidemiology (68) 68
patients (67) 67
polyomavirus infections - virology (66) 66
hiv infections - complications (64) 64
microbiology (64) 64
comorbidity (62) 62
disease progression (62) 62
infections (61) 61
jc virus - immunology (61) 61
polymerase chain reaction (61) 61
infant (60) 60
treatment outcome (60) 60
dna (59) 59
human-immunodeficiency-virus (58) 58
therapy (58) 58
drug therapy (57) 57
leukoencephalopathy, progressive multifocal - etiology (57) 57
abridged index medicus (56) 56
mri (55) 55
medical research (54) 54
multiple sclerosis - drug therapy (54) 54
bk virus (53) 53
hiv infections - drug therapy (53) 53
hypertension (53) 53
leukoencephalopathy, progressive multifocal - pathology (53) 53
analysis (52) 52
medicine, general & internal (52) 52
pathogenesis (52) 52
risk-factors (52) 52
medicine (51) 51
pediatrics (51) 51
psychiatry (51) 51
transplantation (51) 51
age factors (50) 50
oncology (50) 50
multiple-sclerosis (49) 49
pml (48) 48
prospective studies (48) 48
research article (48) 48
tumor virus infections - epidemiology (48) 48
encephalopathy (46) 46
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1063) 1063
French (11) 11
Japanese (9) 9
Spanish (9) 9
German (8) 8
Russian (3) 3
Dutch (2) 2
Finnish (2) 2
Italian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


世界胃肠病学杂志:英文版, ISSN 1007-9327, 2016, Volume 22, Issue 24, pp. 5548 - 5557
AIM: To determine risk factors for early neurologic complications(NCs) after liver transplantation from perspective of recipient, donor, and surgeon. METHODS:... 
Risk;Liver | syndromes;Donor;Learning | curve | transplantation;Neurotoxicity | Risk | Donor | Learning curve | Neurotoxicity syndromes | Liver transplantation | MORTALITY | MANAGEMENT | RECIPIENTS | DELIRIUM | NONCARDIAC SURGERY | PREDICTORS | NERVOUS-SYSTEM COMPLICATIONS | INDEX | GASTROENTEROLOGY & HEPATOLOGY | HEPATIC-ENCEPHALOPATHY | AGE | Delirium - epidemiology | Liver Transplantation | Age Factors | Humans | Middle Aged | Male | Case-Control Studies | Adult | Female | Stroke - epidemiology | Length of Stay - statistics & numerical data | Body Mass Index | Brain Diseases - epidemiology | Mental Disorders - epidemiology | Risk Assessment | Tacrolimus - blood | Graft Rejection - prevention & control | Myelinolysis, Central Pontine - epidemiology | Risk Factors | Posterior Leukoencephalopathy Syndrome - epidemiology | Consciousness Disorders - epidemiology | Postoperative Complications - epidemiology | Psychotic Disorders - epidemiology | Tacrolimus - adverse effects | Intraabdominal Infections - epidemiology | Neurotoxicity Syndromes - etiology | Adrenal Cortex Hormones - adverse effects | Mycophenolic Acid - adverse effects | Seizures - epidemiology | Taiwan - epidemiology | Sex Factors | Tissue Donors - statistics & numerical data | Immunosuppressive Agents - adverse effects | Hepatic Encephalopathy - epidemiology | Neurotoxicity Syndromes - epidemiology | Posterior Leukoencephalopathy Syndrome - chemically induced | Preoperative Period | Case Control Study
Journal Article
Journal Article
Gut, ISSN 0017-5749, 05/2017, Volume 66, Issue 5, pp. 839 - 851
ObjectiveVedolizumab is a gut-selective antibody to α4β7 integrin for the treatment of ulcerative colitis (UC) and Crohn's disease (CD). We report an... 
INFLAMMATORY-BOWEL-DISEASE | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | OPPORTUNISTIC INFECTIONS | FOLLOW-UP | RISK | EXPERIENCE | COHORT | INDUCTION | GASTROENTEROLOGY & HEPATOLOGY | ADVERSE EVENTS | MAINTENANCE THERAPY | Tuberculosis - epidemiology | Age Factors | Humans | Middle Aged | Male | Narcotics - therapeutic use | Clostridium Infections - epidemiology | Adrenal Cortex Hormones - therapeutic use | Incidence | Young Adult | Treatment Failure | Infusions, Intravenous - adverse effects | Gastrointestinal Agents - immunology | Adult | Female | Colitis, Ulcerative - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Risk Factors | Sepsis - epidemiology | Chemical and Drug Induced Liver Injury - epidemiology | Randomized Controlled Trials as Topic | Crohn Disease - drug therapy | Gastrointestinal Agents - therapeutic use | Gastrointestinal Agents - adverse effects | Antibodies, Monoclonal, Humanized - immunology | Antibodies, Neutralizing - blood | Leukoencephalopathy, Progressive Multifocal - epidemiology | Neoplasms - epidemiology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Drug therapy | Crohn's disease | Ulcerative colitis | Clinical trials | Infections | Malignancy | Patients | Risk factors | Crohns disease | Inflammatory bowel disease | Studies | Tuberculosis | Tumor necrosis factor | Population | Tumor necrosis factor-TNF | TNF inhibitors | Sepsis | Safety | Drug dosages | Tumors | 1506 | Inflammatory Bowel Disease
Journal Article
Journal Article
Stroke, ISSN 0039-2499, 02/2016, Volume 47, Issue 2, pp. 410 - 416
Journal Article